Clinical Research Directory
Browse clinical research sites, groups, and studies.
Patient-Derived Xenografts to Reduce Cancer Health Disparities
Sponsor: University of California, Davis
Summary
This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of therapeutic treatments.
Official title: University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities
Key Details
Gender
All
Age Range
21 Years - 100 Years
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2019-11-12
Completion Date
2027-06
Last Updated
2026-08-20
Healthy Volunteers
No
Conditions
Interventions
Biospecimen Collection
Undergo collection of tumor tissue, blood, saliva, and urine samples
Locations (2)
UC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California, United States
University of California Davis Comprehensive Cancer Center
Sacramento, California, United States